| Literature DB >> 35453264 |
Yuan Wang1,2, Evgenia Glukhov3, Yifan He3, Yayue Liu1,2, Longjian Zhou1,2, Xiaoxiang Ma1,2, Xueqiong Hu1, Pengzhi Hong1,2, William H Gerwick3, Yi Zhang1,2,3.
Abstract
Co-culture is known as an efficient way to explore the metabolic potential of fungal strains for new antibiotics and other therapeutic agents that could counter emerging health issues. To study the effect of co-culture on the secondary metabolites and bioactivities of two marine strains, Aspergillus terreus C23-3 and Aspergillus. unguis DLEP2008001, they were co-cultured in live or inactivated forms successively or simultaneously. The mycelial morphology and high-performance thin layer chromatography (HPTLC) including bioautography of the fermentation extracts were recorded. Furthermore, the agar cup-plate method was used to compare the antimicrobial activity of the extracts. Based on the above, liquid chromatography-photodiode array-tandem mass spectrometry (LC-PDA-MS/MS) together with Global Natural Products Social molecular networking (GNPS) and multiple natural products database mining were used to further analyze their secondary metabolite variations. The comprehensive results showed the following trends: (1) The strain first inoculated will strongly inhibit the growth and metabolism of the latter inoculated one; (2) Autoclaved A. unguis exerted a strong inducing effect on later inoculated A. terreus, while the autoclaved A. terreus showed high stability of its metabolites and still potently suppressed the growth and metabolism of A. unguis; (3) When the two strains are inoculated simultaneously, they both grow and produce metabolites; however, the A. terreus seemed to be more strongly induced by live A. unguis and this inducing effect surpassed that of the autoclaved A. unguis. Under some of the conditions, the extracts showed higher antimicrobial activity than the axenic cultures. Totally, A. unguis was negative in response but potent in stimulating its rival while A. terreus had the opposite effect. Fifteen MS detectable and/or UV active peaks showed different yields in co-cultures vs. the corresponding axenic culture. GNPS analysis assisted by multiple natural products databases mining (PubChem, Dictionary of Natural Products, NPASS, etc.) gave reasonable annotations for some of these peaks, including antimicrobial compounds such as unguisin A, lovastatin, and nidulin. However, some of the peaks were correlated with antagonistic properties and remain as possible novel compounds without mass or UV matching hits from any database. It is intriguing that the two strains both synthesize chemical 'weapons' for antagonism, and that these are upregulated when needed in competitive co-culture environment. At the same time, compounds not useful in this antagonistic setting are downregulated in their expression. Some of the natural products produced during antagonism are unknown chlorinated metabolites and deserve further study for their antimicrobial properties. In summary, this study disclosed the different responses of two Aspergillus strains in co-culture, revealed their metabolic variation, and displayed new opportunities for antibiotic discovery.Entities:
Keywords: Aspergillus terreus; Aspergillus unguis; LC-PDA-MS/MS; antimicrobial activity; co-culture; database mining; molecular network
Year: 2022 PMID: 35453264 PMCID: PMC9031932 DOI: 10.3390/antibiotics11040513
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1The morphology of axenic cultures and co-cultures in different experiments (28 days in total). (G1–G7), respectively, represent: axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), livT-livU (G7).
Figure 2HPTLC fingerprints of the axenic and co-cultural extracts. (A) is the UV images of experiments G1–G7 under 254 nm (the sample numbers were marked with pencil below the starting line). (B) is the UV images of G1–G7 under 365 nm. (C) is the image of sulfuric acid-anisaldehyde colorized plate of G1–G7. (D) is the image of potassium ferricyanide-ferric chloride (PFFC) colorized plate of G1–G7. (E) is the DPPH free radical scavenging autographic image of G1–G7. (F) is acetylcholinesterase inhibitory bioautographic image of G1–G7. The developing agent was chloroform:methanol = 20:1 (v/v). The rulers beside the TLC plate are taken as references for Rf value calculation. The yellow or red arrows mark the new metabolites produced only under co-cultural conditions.
The total extract amounts and antimicrobial activities from experiments G1–G7, which were measured using the Oxford Cup method (dosage: 200 mL/well, concentration = 1 mg/mL, concentration for both controls = 0.1 mg/mL, n = 4).
| Sample | Total Sample | Diameters of Inhibition Zones Against Indicator Microbes (mm) # | |||||||
|---|---|---|---|---|---|---|---|---|---|
| MRSA |
|
|
|
|
|
|
| ||
| axU (G1) | 345 ± 40 | 15.7 ± 0.6 | 13.2 ± 0.5 | 14.0 ± 0.9 | 18.6 ± 0.9 | 17.8 ± 0.8 | 17.1 ± 1.2 | - | 13 ± 0.5 |
| axT (G2) | 624 ± 10 | - | - | - | 7.3 ± 0.4 | 8.1 ± 0.6 | 9.3 ± 0.5 | - | - |
| iacU-livT (G3) | 560 ± 20 | - | 7.5 ± 0.8 | 8.9 ± 0.9 | 11.8 ± 0.4 | 7.3 ± 0.9 | 7.1 ± 0.5 | - | 14.2 ± 0.7 |
| livU-livT (G4) | 309 ± 30 | 13.0 ± 0.4 | 15.7 ± 0.5 | 15.6 ± 1.0 | 17.8 ± 0.6 | 16.2 ± 0.6 | 17.4 ± 0.5 | - | 11.7 ± 0.5 |
| livU/livT (G5) | 420 ± 80 | 10.2 ± 0.6 | 14.3 ± 0.7 | 14.2 ± 0.7 | - | 14.3 ± 0.5 | 18 ± 0.8 | - | 13.0 ± 0.8 |
| iacT-livU (G6) | 440 ± 20 | - | 7.0 ± 0.4 | - | - | 9.6 ± 0.6 | 10.4 ± 0.8 | - | 12.3 ± 0.5 |
| livT-livU (G7) | 638 ± 40 | 8.1 ± 0.3 | - | - | 8. 1 ± 0.9 | - | - | - | 9.2 ± 0.7 |
| Ampicillin | - | 14.1 ± 0.4 | 17.5 ± 0.2 | 19.7 ± 0.5 | 24.1 ± 0.9 | 18.6 ± 0.4 | 16.1 ± 0.6 | 11.3 ± 0.2 | - |
| Ketoconazole | - | - | - | - | - | - | - | - | 16.3 ± 0.8 |
#: three times average ± standard deviation; -: no activity or very weak activity.
Figure 3The antimicrobial activities of representative co-cultures (G3 & G4). The figures (a–h) for G3 & G4 are the antimicrobial results against MRSA, Bacillus subtilis, Pseudomonas aeruginosa, Vibro parahemolyticus, V. alginolyticus, Shewanella putrefaciens, Yersinia pseudotuberculosis, and Candida albicans, sequentially. For some relatively weak inhibition zones, circles in dash lines were used to mark them.
Figure 4The HPLC traces of the culture extracts detected under the UV wavelength of 280 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 5The HPLC traces of the culture extracts detected under the UV wavelength of 360–370 nm and the UV spectra for the featured peaks. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 6The LC-MS traces (base peak chromatographies, BPC) under positive ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
Figure 7The LC-MS traces (base peak chromatographies, BPC) under negative ion mode of the culture extracts. The samples include axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7). The numbers marked on the peaks or in the UV spectra are numbers for the peaks with remarkable yield changes detected by mass spectrometry and are consistent with the peak numbers in Table 2.
The changing folds for the yields of the differential peaks.
| Feature Peak Number | G3(iacU-livT) | G4(livU-livT) | G5(livU/livT) | G6(iacT-livU) | G7(livT-livU) | |
|---|---|---|---|---|---|---|
| G2(axT) | 1 | ↑1.58 | ||||
| 2 | ↑1.59 | ↑1.96 | ↑2.11 | ↑2.24 | ↑2.46 | |
| 5 | ↓0.23 | ↑1.49 | ↑3.49 | |||
| 6 | ↓0.7 | ↓0.72 | ||||
| 7 | ↓0.21 | ↑3.57 | ↑3.15 | ↑4.42 | ||
| 8 | ↓0.52 | |||||
| 9 | ||||||
| 10 | ↓<0.01 | ↓<0.01 | ↓0.64 | ↑1.36 | ||
| 11 | ↓0.52 | ↑1.33 | ↑3.03 | |||
| 12 | ↓0.2 | ↓0.57 | ||||
| 13 | ↓0.27 | ↓0.91 | ||||
| G1(axU) | 2 | ↑4.57 | ||||
| 3 | ↑3.46 | ↑3.08 | ||||
| 4 | ↑3.65 | ↑3.48 | ↓0.78 | |||
| 15 | ↓0.23 | ↓0.56 | ↓0.5 | |||
| 14 | ↑1 |
Note: ↓: Production decreased fivefold and more; ↓: Production decreased less than fivefold; ↑: Production increased fivefold and more; ↑: Production increased less than fivefold; ↑: New metabolite (in large quantities) in co-culture; ↑: New metabolite (in small amounts) in co-culture.
Multiple database mining of the main peaks that show remarkably different yields in base peak chromatographies (BPCs) of their LC-MS profiles using positive and negative modes of ionization.
| Peak | Presence in | Retention | UV | Compound Hits | Molecular | Libraries & IDs | MS2 | Molecular | UV Maximum | Bioresource | DOI | Biological | Structures Code of the | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | G2, G7 | 309.10 [M + H]+ | 1.67 | 232 | 1,4-Bis(piperidin-1-ylmethyl)piperazine-2,5-dione | 308.33 | Dictionary of Natural Products | N/A | C16H28N4O2 | N/A (isolate amide) |
| N/A | N/A |
|
| 2 | G1–G7 | 679.59 [M + H]+ | 2.87 | 231 | 3β-(β-D-glucopyranosyloxy)olean-12-ene-23,28,30-trioic acid | 678.81 | NMRDATA, 1331571; Natural Product Atlas, NPA026397; Pubchem, 146682840 | N/A | C36H54O12 | N/A (isolate double bonds) |
| 10.1002/cbdv.201900237 | anti-melanogenic and anti-allergic activity |
|
| 3 | G1, G4, G5 | 777.38 [M + H]+ | 6.40 | 231 | Aspergilasine B | 775.84 | NMRDATA, 999923; Dictionary of Natural Products | N/A | C42H49NO13 | 202, 240 |
| 10.1021/acs.orglett.7b02146 | no inhibitory activities againest seven cancer cell lines up to a concentration of 40μM. |
|
| 4 | G1, G3–G7 | 759.36 [M + H]+ | 7.81 | 230, | Unguisin A | 758.92 | NMRDATA, 29553 | N/A | C40H54N8O7 | 290, 281, 274, 219 |
| 10.1021/np980539z;10.1039/C7OB00316A | moderately inhibited |
|
| 5 | G2, G7 | 585.27 [M + H]+ | 9.30 | 229, | Aspergilol A | 584.62 | NMRDATA, 895659; Pubchem, 132915662; Natural Product Atlas, NPA009011; Dictionary of Natural Products | N/A | C34H32O9 | 196, 293, 452 |
| 10.1016/j.tet.2015.10.038 | possessing antioxidant activities |
|
| Aspergilol B | 584.61 | Dictionary of Natural Products | N/A | C34H32O9 | 194, 293, 462 |
| 10.1016/j.tet.2015.10.038 | possessing antioxidant activities |
| |||||
| Aspergilol G | 584.61 | Dictionary of Natural Products | N/A | C34H32O9 | 206, 265, 295, 458 |
| 10.1016/J.BMCL.2017.01.032 | N/A |
| |||||
| 6 | G2, G6, G7 | 527.22 [M + H]+ | 9.99 | 240, | Territrem B | 526.57 | GNPS, CCMSLIB00005436075 | 0.70 | C29H34O9 | 195, 220, 236, 330, 284 |
| 10.3390/md12126113 | strong inhibitory activity against acetylcholinesterase, potent antifouling activity |
|
| 526.57 | Dictionary of Natural Products | N/A | ||||||||||||
| 7 | G2, G5–G7 | 427.26 [M + Na]+ | 11.80 | 243, 275, 313, 364 | Lovastatin | 404.54 | GNPS, CCMSLIB00000852214 | 0.76 | C24H36O5 | 231, 238, 247 |
| 10.1080/10826068.2020.1805624 | the competitive inhibitors of the enzyme hydroxy-methyl-glutaryl coenzyme A (HMG-CoA) reductase |
|
| 404.54 | Dictionary of Natural Products | N/A | ||||||||||||
| 8 | G5–G7 | 459.31 [M + H]+ | 12.15 | 246, | Unannotated statin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Aspernolide D | 458.46 | NMRDATA, 152713; Pubchem, 46930025; Natural Product Atlas, NPA003511 | N/A | C24H26O9 | 290 |
| 10.1248/cpb.58.1221 | Inactive against all bacterial strains |
| |||||
| 9 | G2, G7 | 507.38 [M + H]+ | 16.26 | N/A (no obvious absorption) | Terretonin G | 506.58 | NMRDATA, 809567; Dictionary of Natural Products | N/A | C27H38O9 | End absorption | 10.1038/ja.2014.46 | Moderate antimicrobial activity against Gram-positive bacteria |
| |
| 10 | G2, G5–G7 | 1106.49 [M + Na]+ | 17.78 | 272, | Epichloenin A | 1083.15 | Dictionary of Natural Products | N/A | C46H74N12O18 | N/A (containing a,b-unsaturated amides) |
| 10.1371/journal.ppat.1003332 | as an important molecular/cellular signal for controlling fungal growth and hence the symbiotic interaction. |
|
| Astalluminoxide | 1084.22 | Natural Product Atlas, NPA032177 | N/A | C60H66AlN9O9 | 201, 222, 272, 349 |
| 10.1016/j.tet.2020.131496 | moderate to weak cytotoxicity against both cancerous and non-cancerous cells. |
| |||||
| 11 | G2, G5–G7 | 1135.35 [M + Na]+ | 18.20 | 273, | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 12 | G2, G7 | 606.07 [M − H]− | 2.16 | 231 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 13 | G2, G7 | 362.92 [M − H]− | 8.87 | 226, | Austamide | 363.41 | Dictionary of Natural Products | N/A | C21H21N3O3 | 234, 256, 282, 392 |
| 10.1016/s0040-4039(01)97170-9 | toxic to ducklings |
|
| Circumdatin B | 363.37 | Dictionary of Natural Products | N/A | C20H17N3O4 | 284, 358 |
| 10.1021/jo981536u | Inactive in the assay against NCI’s 60 cancer cell line panel |
| |||||
| Asperimide A | 363.41 | Natural Product Atlas, NPA028229 | N/A | C22H21NO4 | 229, 278, 360 |
| 10.1016/j.fitote.2018.10.011 | not found exhibited cytotoxicity |
| |||||
| 14 | G6, G7 | 367.19 [M − H]− | 11.54 | 244, 275, 313, 361 | Cosmochlorin A | 369.24 | Dictionary of Natural Products; Natural Product Atlas, NPA030107 | N/A | C18H18Cl2O4 | 323 | 10.1016/j.phytol.2016.09.007 | moderate antimicrobial activity against gram-positive bacteria and fungi; |
| |
| Cosmochlorin B | 369.24 | Dictionary of Natural Products; Natural Product Atlas, NPA030108 | N/A | C18H18Cl2O4 | 230, 290 | 10.1016/j.phytol.2016.09.007 | Inactive against microbes; |
| ||||||
| Cosmochlorin C | 369.24 | Dictionary of Natural Products; Natural Product Atlas, NPA030109 | N/A | C18H18Cl2O4 | 323 | 10.1016/j.phytol.2016.09.007 | Similar antimicrobial activity to cosmochlorin A |
| ||||||
| Penicillixanthone | 369.15 | Dictionary of Natural Products; Natural Product Atlas, NPA008373 | N/A | C16H10Cl2O6 | 230, 294, 369 | 10.1016/j.tet.2014.05.105 | No antimycobacterial and cytotoxic activities |
| ||||||
| 15 | G1, G3–G6 | 441.07 [M − H]− | 13.50 | 237, | Nidulin | 443.70 | GNPS, CCMSLIB00005436077 | 0.70 | C20H17Cl3O5 | 267 |
| 10.1055/s-0031-1298228 | aromatase inhibitory and antimicrobial |
|
| Pubchem, 6450195; Dictionary of Natural Products | N/A |
N/A: indicates not applicable or with no record or having limited accessibility. Compounds can be found by name in the Dictionary of Natural Product online database with more details and ID numbers. The asterisks (*) mark hits from databases with relatively higher reliability based on their similarities, including not only molecular weights, but also at least one of the following characteristics, like GNPS MS2 similarity, UV features, isotopic patterns (for chlorinated compounds), and taxonomy, to the featured peaks.
Figure 8Annotated compound structures for the peaks 1–15. The asterisks (*) mark hits from databases with relatively higher reliability based on their similarities, including not only molecular weights, but also at least one of the following characteristics like GNPS MS2 similarity, UV features, isotopic patterns (for chlorinated compounds), and taxonomy, to the featured peaks. Compounds 10-1 and 10-2 represent two alternative annotations for peak 10 (see Table 3 for further data on each of these annotations). This terminology also applies for the other base compound numbers.
Figure 9The GNPS molecular network based on positive ion MS/MS spectral similarity, showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., : axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster for statins including the sodiated ion of peak 7 (lovastatin). (B) is an enlarged cluster containing a possible fusarine-like siderophore. (C) is an enlarged cluster containing heme B. (D) is an enlarged cluster containing protonated ion of peak 7. (E) is an enlarged cluster containing peak 6 (territrem B). (F) conclude two nodes annotated as a diketopiperazine and a simvastatin fragment. (G) is a node annotated as a cyclopeptide.
Figure 10The GNPS molecular network based on negative ion MS/MS spectral similarity showing a selection of amplified clusters. The nodes display the measured average masses of the molecular ions with identical MS/MS spectra. The sizes of the nodes reflect the relative amount of the corresponding compounds. The different colors of sections in the nodes represent different samples, i.e., : axU (G1), axT (G2), iacU-livT (G3), livU-livT (G4), livU/livT (G5), iacT-livU (G6), and livT-livU (G7), respectively. (A) is an enlarged cluster containing peak 15 (nidulin). (B) is an enlarged cluster containing nornidulin.
Figure 11The interpretation of MS/MS spectrum of peak 4 (cyclopeptide unguisin A).
Chromatographic analysis conditions.
| Injection Volume (μL) | Elution Conditions | Flow Rate (mL/min) | |
|---|---|---|---|
| Time (min) | Proportion | ||
| 25 | 0.00–1.00 | 30% ACN-H2O | 0.6 |
| 1.00–10.00 | 30–99% ACN-H2O | ||
| 10.00–16.00 | 99% ACN-H2O | ||
| 16.00–16.20 | 99–30% ACN-H2O | ||
| 16.20–20.00 | 30% ACN-H2O | ||
Note: The Mobile phase contained 0.1% formic acid.